United States · Bill · HR
H.R. 7709 (118th)
PREPARE ACT of 2024
Introduced
15 March 2024
Last action
22 March 2024 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Bacon, Don [R-NE-2]
Subjects
Healthcare
Source updated
16 December 2024
Summary
Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines Act of 2024 or the PREPARE ACT of 2024 This bill establishes the Strategic Active Pharmaceutical Ingredient Reserve. The Department of Health and Human Services (HHS) must annually publish a public list of essential generic medicines that are medically necessary to have available at all times. HHS must report and implement a plan to establish the reserve, which must be designed to minimize the impact of an interruption or reduction in imports of (1) key starting materials (including active pharmaceutical ingredients) for essential generic medicines, and (2) finished dosage forms of essential generic medicines for which key starting materials are not imported. The plan must also contain provisions to strengthen domestic capacity for active pharmaceutical ingredient production, storage, and conversion. Within one year of this bill's enactment, the plan must include at least 25 of the essential generic medicines on the required list. The plan must add at least 25 medicines each year until the full list is covered. HHS must prioritize domestically manufactured key starting materials for the reserve to the maximum extent possible. A manufacturer of an essential generic medicine that switches to an active pharmaceutical ingredient sourced through the reserve shall not have to update the approved application for that medicine. The Government Accountability Office must report to Congress on active pharmaceutical ingredient manufacturing, including the time and costs needed to develop domestic manufacturing capabilities.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 March 2024
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
15 March 2024
Introduced
Introduced in House
Source: IntroReferral
15 March 2024
Introduced
Introduced in House
Source: IntroReferral
22 March 2024
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 15 March 2024 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 15 March 2024
Introduced in House (PDF)
Introduced in House · EN · 15 March 2024
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 15 March 2024
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Spanberger, Abigail Davis [D-VA-7] · D · Sponsor
- Rep. Bacon, Don [R-NE-2] · R · Sponsor
- · hsif00 · Standing
Related records
- related to ← PREPARE ACT of 2021
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/7709
- Open data entity: https://api.congress.gov/v3/bill/118/hr/7709
- us · 118-hr-7709 · source updated 16 December 2024